Ginkgo Bioworks Holdings Inc (NYSE: DNA) is -36.69% lower on its value in year-to-date trading and has touched a low of $1.03 and a high of $2.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNA stock was last observed hovering at around $1.09 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $1.07, the stock is -11.72% and -15.73% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.28 million and changing -1.83% at the moment leaves the stock -34.55% off its SMA200. DNA registered -15.75% loss for a year compared to 6-month loss of -38.15%. The firm has a 50-day simple moving average (SMA 50) of $6.37 and a 200-day simple moving average (SMA200) of -$1.95.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -23.57% gain in the last 1 month and extending the period to 3 months gives it a -38.86%, and is -1.83% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.33% over the week and 7.35% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 1218 employees, a market worth around $2.17B and $251.46M in sales. Profit margin for the company is -355.08%. Distance from 52-week low is 3.88% and -57.96% from its 52-week high. The company has generated returns on investments over the last 12 months (-67.69%).
Ginkgo Bioworks Holdings Inc quarterly earnings per share for the current quarter are estimated at -$0.08 with sales reaching $46.43M over the same period.The EPS is expected to grow by 30.58% this year, but quarterly earnings will post -11.10% year-over-year. Quarterly sales are estimated to shrink -42.50% in year-over-year returns.
Ginkgo Bioworks Holdings Inc (DNA) Top Institutional Holders
440 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 89.76% of the company’s shares. The shares outstanding are 1.53B, and float is at 1.34B with Short Float at 19.05%. Institutions hold 83.72% of the Float.
The top institutional shareholder in the company is Baillie Gifford and Company with over 236.29 million shares valued at $252.83 million. The investor’s holdings represent 14.31% of the DNA Shares outstanding. As of Dec 30, 2023, the second largest holder is ARK Investment Management, LLC with 198.61 million shares valued at $212.51 million to account for 12.03% of the shares outstanding. The other top investors are Viking Global Investors, L.P. which holds 143.09 million shares representing 8.67% and valued at over $153.1 million, while Vanguard Group Inc holds 8.04% of the shares totaling 132.78 million with a market value of $142.07 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
The most recent transaction is an insider sale by Dmytruk Mark E.,the company’s. SEC filings show that Dmytruk Mark E. sold 38,826 shares of the company’s common stock on Mar 04 ’24 at a price of $1.26 per share for a total of $48765.0. Following the sale, the insider now owns 0.81 million shares.
Ginkgo Bioworks Holdings Inc disclosed in a document filed with the SEC on Feb 02 ’24 that Dmytruk Mark E. () sold a total of 39,569 shares of the company’s common stock. The trade occurred on Feb 02 ’24 and was made at $1.21 per share for $47799.0. Following the transaction, the insider now directly holds 0.76 million shares of the DNA stock.
Still, SEC filings show that on Jan 04 ’24, Kelly Jason R () disposed off 100,000 shares at an average price of $1.55 for $0.16 million. The insider now directly holds 3,894,680 shares of Ginkgo Bioworks Holdings Inc (DNA).
